Ugur Uslu (U Uslu)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 21

Top Topics

Locally Advanced

Basal Cell Carcinoma

Top Venues

Proceedings of the National Academy of Sciences of the United States of America

Experimental dermatology

Clinical and experimental dermatology

Science advances

This page only lists publications with an associated author ORCID identifier.

Publications

Ugur Uslu, Lijun Sun, María Sofía Castelli, Amanda V Finck, Charles-Antoine Assenmacher, Regina M Young, Zhijian J Chen, Carl H June
The STING agonist IMSA101 enhances chimeric antigen receptor T cell function by inducing IL-18 secretion. Nature communications 15 (1) (2024)
Ugur Uslu, Lijun Sun, María Sofía Castelli, Amanda V Finck, Charles-Antoine Assenmacher, Regina M Young, Zhijian J Chen, Carl H June
The STING agonist IMSA101 enhances chimeric antigen receptor T cell function by inducing IL-18 secretion. Nature communications 15 (1) (2024)
Uri Amit, Ugur Uslu, Ioannis I Verginadis, Michele M Kim, Seyyedeh Azar Oliaei Motlagh, Eric S Diffenderfer, Charles-Antoine Assenmacher, Sandra Bicher, Sebastian J Atoche, Edgar Ben-Josef, Regina M Young, Carl H June, Constantinos Koumenis
Proton radiation boosts the efficacy of mesothelin-targeting chimeric antigen receptor T cell therapy in pancreatic cancer. Proceedings of the National Academy of Sciences of the United States of America 121 (31) (2024)
Uri Amit, Ugur Uslu, Ioannis I Verginadis, Michele M Kim, Seyyedeh Azar Oliaei Motlagh, Eric S Diffenderfer, Charles-Antoine Assenmacher, Sandra Bicher, Sebastian J Atoche, Edgar Ben-Josef, Regina M Young, Carl H June, Constantinos Koumenis
Proton radiation boosts the efficacy of mesothelin-targeting chimeric antigen receptor T cell therapy in pancreatic cancer. Proceedings of the National Academy of Sciences of the United States of America 121 (31) (2024)
Uri Amit, Ugur Uslu, Ioannis I Verginadis, Michele M Kim, Seyyedeh Azar Oliaei Motlagh, Eric S Diffenderfer, Charles-Antoine Assenmacher, Sandra Bicher, Sebastian J Atoche, Edgar Ben-Josef, Regina M Young, Carl H June, Constantinos Koumenis
Proton radiation boosts the efficacy of mesothelin-targeting chimeric antigen receptor T cell therapy in pancreatic cancer. Proceedings of the National Academy of Sciences of the United States of America 121 (31) (2024)
Uri Amit, Ugur Uslu, Ioannis I Verginadis, Michele M Kim, Seyyedeh Azar Oliaei Motlagh, Eric S Diffenderfer, Charles-Antoine Assenmacher, Sandra Bicher, Sebastian J Atoche, Edgar Ben-Josef, Regina M Young, Carl H June, Constantinos Koumenis
Proton radiation boosts the efficacy of mesothelin-targeting chimeric antigen receptor T cell therapy in pancreatic cancer. Proceedings of the National Academy of Sciences of the United States of America 121 (31) (2024)
Ugur Uslu, Tong Da, Charles-Antoine Assenmacher, John Scholler, Regina M Young, Julia Tchou, Carl H June
Chimeric antigen receptor T cells as adjuvant therapy for unresectable adenocarcinoma. Science advances 9 (2) (2023)
Ugur Uslu, Carl H June
T-cell Therapies Targeting Multiple Cancer Antigens: The Power of Many. Cancer immunology research (2023)
Ugur Uslu, Tong Da, Charles-Antoine Assenmacher, John Scholler, Regina M Young, Julia Tchou, Carl H June
Chimeric antigen receptor T cells as adjuvant therapy for unresectable adenocarcinoma. Science advances 9 (2) (2023)
Ugur Uslu, Carl H June
CAR T-cell Therapy Meets Clonal Hematopoiesis. Blood cancer discovery 3 (5) (2022)
Ugur Uslu
Driving CAR T cells towards dermatologic oncology. Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG 19 (3) (2021)
Bianca Simon, Ugur Uslu
Fasten the seat belt: Increasing safety of CAR T-cell therapy. Experimental dermatology 29 (11) (2020)
Bianca Simon, Dennis C Harrer, Beatrice Schuler-Thurner, Gerold Schuler, Ugur Uslu
Arming T Cells with a gp100-Specific TCR and a CSPG4-Specific CAR Using Combined DNA- and RNA-Based Receptor Transfer. Cancers 11 (5) (2019)
Bianca Simon, Ugur Uslu
CAR-T cell therapy in melanoma: A future success story? Experimental dermatology 27 (12) (2019)
Bianca Simon, Dennis C Harrer, Beatrice Schuler-Thurner, Niels Schaft, Gerold Schuler, Jan Dörrie, Ugur Uslu
The siRNA-mediated downregulation of PD-1 alone or simultaneously with CTLA-4 shows enhanced in vitro CAR-T-cell functionality for further clinical development towards the potential use in immunotherapy of melanoma. Experimental dermatology 27 (7) (2019)
Jonas Bochem, Henning Zelba, Teresa Amaral, Janine Spreuer, Daniel Soffel, Thomas Eigentler, Nikolaus Benjamin Wagner, Ugur Uslu, Patrick Terheyden, Friedegund Meier, Claus Garbe, Graham Pawelec, Benjamin Weide, Kilian Wistuba-Hamprecht
Peripheral PD-1+CD56+ T-cell frequencies correlate with outcome in stage IV melanoma under PD-1 blockade. PloS one 14 (8) (2019)
Bianca Simon, Manuel Wiesinger, Johannes März, Kilian Wistuba-Hamprecht, Benjamin Weide, Beatrice Schuler-Thurner, Gerold Schuler, Jan Dörrie, Ugur Uslu
The Generation of CAR-Transfected Natural Killer T Cells for the Immunotherapy of Melanoma. International journal of molecular sciences 19 (8) (2018)
L Löbelenz, S Schliep, P Wörl, Ugur Uslu
Eosinophilic polymorphic and pruritic eruption associated with radiotherapy: case report and overview of disease characteristics. Clinical and experimental dermatology 44 (5) (2018)
Ugur Uslu, S Schliep, M Erdmann
Rapid development of cutaneous melanoma metastases after herpes zoster infection in a radiotherapy field. Clinical and experimental dermatology 43 (1) (2017)
Ugur Uslu, F Heppt, M Sticherling
Secondary syphilis infection under treatment with ustekinumab. Clinical and experimental dermatology 42 (7) (2017)
Ugur Uslu, Franz Heppt, Michael Erdmann
Intracorneal Hematoma Showing Clinical and Dermoscopic Features of Acral Lentiginous Melanoma. Case reports in dermatological medicine 2017 (2017)